Howard Li

2.6k total citations
48 papers, 1.9k citations indexed

About

Howard Li is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Howard Li has authored 48 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Oncology and 13 papers in Immunology. Recurrent topics in Howard Li's work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (6 papers) and Immune cells in cancer (6 papers). Howard Li is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (6 papers) and Immune cells in cancer (6 papers). Howard Li collaborates with scholars based in United States, Japan and Italy. Howard Li's co-authors include Raphael A. Nemenoff, Jeff Hasty, Arthur Prindle, Joanna M. Poczobutt, Mary C. Weiser-Evans, Gabriel A. Kwong, Matthew Skalak, Kaitlin Allen, Sangeeta N. Bhatia and Tal Danino and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Clinical Oncology.

In The Last Decade

Howard Li

48 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Howard Li United States 23 1.0k 601 439 293 292 48 1.9k
Jean‐Philippe Theurillat Switzerland 19 1.5k 1.5× 588 1.0× 355 0.8× 396 1.4× 150 0.5× 30 2.8k
Qi‐Xiang Li China 25 875 0.9× 587 1.0× 346 0.8× 256 0.9× 127 0.4× 73 1.8k
Guangfu Li United States 28 984 1.0× 821 1.4× 644 1.5× 380 1.3× 183 0.6× 96 2.4k
Camilla Basso Switzerland 8 769 0.8× 547 0.9× 888 2.0× 365 1.2× 226 0.8× 8 2.0k
Wei Tang United States 29 1.5k 1.5× 691 1.1× 340 0.8× 687 2.3× 79 0.3× 88 2.8k
Fuming Qiu China 26 863 0.9× 730 1.2× 638 1.5× 498 1.7× 192 0.7× 55 2.1k
Suman K. Vodnala United States 16 900 0.9× 841 1.4× 730 1.7× 256 0.9× 257 0.9× 25 2.1k
Vladislav V. Glinsky United States 23 1.3k 1.3× 569 0.9× 845 1.9× 175 0.6× 231 0.8× 48 2.3k
Qin Tang China 25 1.1k 1.1× 430 0.7× 361 0.8× 415 1.4× 255 0.9× 54 1.9k

Countries citing papers authored by Howard Li

Since Specialization
Citations

This map shows the geographic impact of Howard Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Li more than expected).

Fields of papers citing papers by Howard Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Li. The network helps show where Howard Li may publish in the future.

Co-authorship network of co-authors of Howard Li

This figure shows the co-authorship network connecting the top 25 collaborators of Howard Li. A scholar is included among the top collaborators of Howard Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard Li. Howard Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Romano, Giulia, Giovanni Nigita, Alessandro La Ferlita, et al.. (2024). METTL3 alters capping enzyme expression and its activity on ribosomal proteins. Scientific Reports. 14(1). 27720–27720. 1 indexed citations
2.
Guo, Chunqing, Xiaoyan Deng, Anthony C. Faber, et al.. (2024). The Innate Immune System and the TRAIL–Bcl-XL Axis Mediate a Sex Bias in Lung Cancer and Confer a Therapeutic Vulnerability in Females. Cancer Research. 84(24). 4140–4155. 2 indexed citations
3.
Li, Howard, Tytus Bernaś, Jennifer E. Koblinski, et al.. (2023). High-Dose Acetaminophen with N-acetylcysteine Rescue Inhibits M2 Polarization of Tumor-Associated Macrophages. Cancers. 15(19). 4770–4770. 5 indexed citations
4.
Shows, Kathryn H., et al.. (2023). Sex Differences in Lung Cancer. Cancers. 15(12). 3111–3111. 35 indexed citations
5.
Wu, Y. Jeffrey, Chetna Sharon, Howard Li, et al.. (2021). High dose acetaminophen inhibits STAT3 and has free radical independent anti-cancer stem cell activity. Neoplasia. 23(3). 348–359. 13 indexed citations
6.
Neuwelt, Alexander, Abigail K. Kimball, Amber M. Johnson, et al.. (2020). Cancer cell-intrinsic expression of MHC II in lung cancer cell lines is actively restricted by MEK/ERK signaling and epigenetic mechanisms. Journal for ImmunoTherapy of Cancer. 8(1). e000441–e000441. 37 indexed citations
7.
Ng, Terry L., Amber M. Johnson, Raphael A. Nemenoff, et al.. (2020). Prospective Observational Study Revealing Early Pulmonary Function Changes Associated With Brigatinib Initiation. Journal of Thoracic Oncology. 16(3). 486–491. 1 indexed citations
8.
Sippel, Trisha R., Amber M. Johnson, Howard Li, et al.. (2019). Activation of PPARγ in Myeloid Cells Promotes Progression of Epithelial Lung Tumors through TGFβ1. Molecular Cancer Research. 17(8). 1748–1758. 14 indexed citations
9.
Bullock, Bonnie, Abigail K. Kimball, Joanna M. Poczobutt, et al.. (2019). Tumor-intrinsic response to IFNγ shapes the tumor microenvironment and anti–PD-1 response in NSCLC. Life Science Alliance. 2(3). e201900328–e201900328. 39 indexed citations
10.
Marrocco, Jordan, Howard Li, Neelima Dubey, et al.. (2018). Epigenetic intersection of BDNF Val66Met genotype with premenstrual dysphoric disorder transcriptome in a cross-species model of estradiol add-back. Molecular Psychiatry. 25(3). 572–583. 24 indexed citations
11.
Kwak, Jeff, Jennifer Laskowski, Howard Li, et al.. (2017). Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression. Cancer Research. 78(1). 143–156. 103 indexed citations
12.
Li, Howard, Maria McSharry, Bonnie Bullock, et al.. (2017). The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade. Cancer Immunology Research. 5(9). 767–777. 128 indexed citations
13.
Galata, Valentina, Christina Backes, Cédric C. Laczny, et al.. (2016). Comparing genome versus proteome-based identification of clinical bacterial isolates. Briefings in Bioinformatics. 19(3). bbw122–bbw122. 7 indexed citations
14.
Wang, Chu-An, David Drasin, Paul Jedlicka, et al.. (2014). Homeoprotein Six2 Promotes Breast Cancer Metastasis via Transcriptional and Epigenetic Control of E-Cadherin Expression. Cancer Research. 74(24). 7357–7370. 45 indexed citations
15.
Malkoski, Stephen P., Sarah M. Haeger, Timothy G. Cleaver, et al.. (2012). Loss of Transforming Growth Factor Beta Type II Receptor Increases Aggressive Tumor Behavior and Reduces Survival in Lung Adenocarcinoma and Squamous Cell Carcinoma. Clinical Cancer Research. 18(8). 2173–2183. 52 indexed citations
16.
Saeedi, Sajad, Liam Paull, Michael Trentini, & Howard Li. (2011). Multiple robot simultaneous localization and mapping. 2011 IEEE/RSJ International Conference on Intelligent Robots and Systems. 3 indexed citations
17.
Li, Howard, Amber Sorenson, Joanna M. Poczobutt, et al.. (2011). Activation of PPARγ in Myeloid Cells Promotes Lung Cancer Progression and Metastasis. PLoS ONE. 6(12). e28133–e28133. 63 indexed citations
18.
Li, Howard, Gregory P. Cosgrove, & Jeffrey J. Swigris. (2009). Dyspnea in a 43-Year-Old Woman With Polycystic Kidney Disease. CHEST Journal. 135(1). 238–243. 4 indexed citations
19.
20.
Bren‐Mattison, Yvette, Amy M. Meyer, Vicki Van Putten, et al.. (2007). Antitumorigenic Effects of Peroxisome Proliferator-Activated Receptor-γ in Non-Small-Cell Lung Cancer Cells Are Mediated by Suppression of Cyclooxygenase-2 via Inhibition of Nuclear Factor-κB. Molecular Pharmacology. 73(3). 709–717. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Philippe Theurillat Breakdown of academic impact, for papers by Qi‐Xiang Li Breakdown of academic impact, for papers by Guangfu Li Breakdown of academic impact, for papers by Camilla Basso Breakdown of academic impact, for papers by Wei Tang Breakdown of academic impact, for papers by Fuming Qiu Breakdown of academic impact, for papers by Suman K. Vodnala Breakdown of academic impact, for papers by Vladislav V. Glinsky Breakdown of academic impact, for papers by Qin Tang
Rankless by CCL
2026